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Heterotopic grafting sites can be useful in producing oocytes for in vitro Fertilization, therefore, maximising
the oocyte yield from the graft by gonadotrophin stimulation would be advantageous. The aim of this study was
to investigate the number and quality of oocytes collected from heterotopic autografted ovary after Pregnant
Mare Serum Gonadothropin (PMSG) induction. Graft recipients were treated either with or without PMSG
stimulation 48 hours prior to graft collection. Ovarian tissue from four weeks old mice (DDY strain) were
autotransplanted under the kidney capsule of the same ovariectomized mice and the oocytes were collected 21
days after autotransplantation. The results showed that the average number of oocytes collected from autografted
ovaries without PMSG induction were 9.0. + 2.8 not significantly different with those received PMSG induction,
10.9 + 5.1. The percentage of matured and fertilized oocytes and the developed embryos from the autografted
ovaries without PMSG induction were 52.4, 33.4, and 26.0%, respectively not significantly different with those
received PMSG induction, 53.2, 35.1, and 29.9%, respectively. The number of oocytes and the capacity to matured,
fertilized and developed were significantly lower (P < 0.05) compared to the superovulated nongrafted (control)
ovaries. In conclusion, PMSG induction on the graft recipients did not significantly increase oocytes yield from
grafted heterotopic ovaries. The number and quality of oocytes produced from the autografted ovaries were lower
than the superovulated nongrafted ovaries, but still can be used for in vitro embryo production after sequential in
vitro maturation and fertilization.
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INTRODUCTION
Ovary as the primary organ in female reproductive
system has two main roles i.e. for producing oocyte and
synthesizing essential hormones for follicles development,
estrous cyclicity and maintenance of the reproductive tract
(Hirshfield 1991). Mammalian ovary contains large number
of various developmental stages follicles. At the time of
birth, cortex of mammalian ovary consist of abundant of
primordial follicles as oocytes resources; those will
develop during puberty (Fortune 1994). Ovaries collected
from slaughter house or from immediately dead animal
contain follicles in various development stages. These
follicles are the oocytes resources used for embryo in
vitro production (Gunasena et al. 1998; Shaw et al. 2000;
Paris et al. 2004). This ovarian follicles will developed to
produce development competence oocytes using in vitro
culture and or grafting techniques (Eppig et al. 2000; Paris
et al. 2004, 2009).
In the ovary, the oocytes developed simultaneously
with the synthesizing and secreting hormones for
supporting the follicles development and estrous cyclicity.
However, in young woman having cancer, treatments such
as irradiation and chemoterapy could lead to the loss of
fertility. In order to protect this fertility, ovaries were
ovariectomized and moved to safe area of the body through
transplantation or cryopreseved (Eppig et al. 2000). After
treatment, the cryopreserved ovary returned to the original
sites (Hernadi et al. 2005). Ovary transplantation combined
with in vitro culture techniques can be used for in vitro
embryo production.
Transplantation is a method of transferring the organ
or tissue to enable the growth of the transplant in vivo.
Based on the correlation between donor and recipient,
transplantation can be autotransplantation (transferring
an organ from one site to the other sites of the same body);
allotransplantation (transferring an organ from one
individual to another individual of the same species) and
xenotransplantation (of different species).
Xenotransplantation is considered as a strategy for
generating viable gametes that can be used to produce
life fertile offspring of endangered species (Paris et al.
2004). Based on the sites, transplantation can be
orthotopic (the same sites) or heterotopic (of the different
site) such as subcutan and kidney capsule (Candy et al.
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2000; Mohammad et al. 2004). Ovary heterotopic
autografted is grafting the ovary in kidney capsule of the
same body after being removed from the original site, the
bursa ovary. The best site for heterotopic transplantation
is the kidney capsule due to its high vascularization (Cox
et al. 1996); however the number and size of the organ to
be transplanted is very limited. Orthotopic grafts permit
natural conception, while  heterotopic grafts will required
in vitro maturation (IVM) and in vitro fertilization (IVF)
for producing embryo (Gosden et al. 1994; Cox et al. 1996;
Almodin et al. 2004a,b; Donnez et al. 2004).
Mouse ovary heterotopic autotransplantation in
kidney capsule restore the estrous cyclicity on day 7 after
transplantation and indicated the growth of follicles with
normal morphology (Mohammad et al. 2004). Heterotopic
ovarian grafts placed under the kidney capsule of mice
yield viable oocytes and after in vitro fertilization resulted
in pregnancy after the embryos were placed in recipient
uterin (Carroll et al. 1990; Waterhouse et al. 2004).
The lifespan of a graft is limited because of the small
size of the graft and follicle loss due to ischaemia after
transplantation (Liu et al. 2002). Heterotopic grafting sites
can be useful in producing oocytes for in vitro
Fertilization (IVF); hence, maximising the oocyte yield from
the graft by gonadotrophin stimulation would be
advantageous. Based on the histological observation,
superovulation treatment on the heterotopic autografted
ovary showed an increased of tertiary follicles (Setiadi
2004). However, the number and quality of oocytes
collected from fully antral follicles of those superovulated
heterotopic autografted ovary need to be further examined,
especially for the in vitro embryo production. Therefore,
this research was aimed to examine the number and quality
of oocytes collected from the fully antral follicles of
heterotopic autografted ovary after Pregnant Mare Serum
Gonadotropin (PMSG) induction.
MATERIALS  AND  METHODS
Experimental Animals. Four weeks old female of DDY
strain mice were used as both ovarian tissue donors and
graft recipients (n = 30). The graft recipient were grouped
in two, group that stimulated with 5 IU PMSG (n = 10) and
those without PMSG treatment (n = 10). Female mice of
the same strain were treated with 5 IU PMSG and used for
control for collection of in vivo matured (ovulated) oocytes
(n = 10). The sperm donors were 12 weeks old male mice of
the same strain. Intra peritoneal (i.p) injection of 5 IU
PMSG was performed 48 hours before oocytes collection
or on day nineteen after autotransplantation in the graft
recipient PSMG treated group.
Heterotopic Autotransplantation. Each female mouse
was used as both ovarian tissue donor and graft recipient
in order to minimize the animal usage. Ovarian grafting
was performed using standard procedures (Mohammad
et al. 2004). Female mice were anaesthetized by
administering each with 0.2 ml i.p. injection containing
1 mg/ml xylazine hydrochloride (Ilium Xylazil-20; Troy
Laboratories, Smithtown, Australia) and 5 mg/ml ketamine
hydrochloride (Ketamine; Parnell Laboratories, Alexandria,
Australia). Once anaesthetized, the dorsal skin of both
mice was swabbed with 70% (v/v) alcohol and a 1 cm
dorsolateral incision was made through the skin and
peritoneum to expose the lipid pad with ovary attached to
it and kidney. Using fine forceps the lipid pad was pulled
out from the abdomen cavity. The lipid pad was clip using
serrefine clamp and the ovary was separated from the
bursa. The excised ovaries were placed in Dulbecco’s
Phosphate Buffered (PBS; Gibco BRL, USA) and were cut
in half before being grafted. Bilateral ovariectomy was
performed on each mouse. A small incision was made into
the kidney capsule and two hemi-ovaries were inserted
under each kidney capsule. The skin was closed with
cotton suture.
Pregnant Mare Serum Gonadotrophin (PMSG)
Induction (Hogan et al. 1986). Nineteen days after
grafting, recipients were divided into two groups as
follows: recipients receiving PMSG (n = 10) and non-
receiving PSMG recipients (n = 10). Mice that were treated
with PMSG were given a single i.p. injection of  5 IU PMSG
(Folligon; Intervet, Australia). Three weeks after grafting,
all graft recipients were killed by cervical dislocation. The
control group did not receive any ovarian grafts (n = 10);
these mice were superovulated with an i.p. injection of
5 IU PMSG (Folligon) followed 48 h by an i.p. injection of
5 IU hCG (Chorulon) and allowed in vivo oocytes
maturation and ovulated.
Oocyte Collection and In Vitro Maturation. The grafts
were collected into PBS medium at 37 oC. The oocytes
were released by puncturing the large (fully) antral follicles
with 26 G needle. At the time of collection, oocytes  were
fully cumulus enclosed (tight cumulus cells) for which the
nuclear status could not be assessed. All oocytes were
cultured in 20-30 μl droplets of kalium simplex optimized
medium (KSOM) supplemented with 10 μg/ml follicle
stimulating hormone (FSH), 50 μg/ml gentamycin sulphate
and 3% (w/v) Bovine Serum Albumine (BSA) covered with
mineral oil and incubated for 24 h at 37 oC, 100% humidity
and 5% CO2 in air. Throughout the experiments
 35 mm
Falcon culture dishes (Becton Dickinson, Franklin Lakes,
NJ, USA) were used.
In control group, the ovulated oocytes were collected
13-14 h after the hCG injection to allow insemination at the
same time as the oocytes from the ovarian grafts. The
oviducts were removed and placed into KSOM medium
and the cumulus mass released by puncturing the
fertilization vesicle of the ampulla.
The number of oocytes collected per graft was noted.
Prior to maturation status evaluation, oocyted from all
groups were denuded with 0.1% hyaluronidase for 10 min
to remove the cumulus cells. Matured oocyte was
indicated by the presence of first polar body (PB I) or the
absence of Germinal vesicle (GV). Matured oocytes were
determined by the presence of PB I.
Sperm Preparation. Male mice were killed by cervical
dislocation and the testes removed. The cauda of the
epididymis were dissected, cut into strips and each cauda
placed into 1 ml KSOM in 6 ml Falcon tubes (Becton
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Dickinson). The sperm were incubated in 5% CO2
incubator at 37 oC, 100% humidity, for 30-60 min. The
insemination drops were then prepared by placing 30 μl
aliquots of this medium containing the sperm into 35 mm
Falcon dishes and then covering them with pre-equilibrated
mineral oil.
In Vitro Fertilization and Embryo Culture. The
oocytes were washed in three 20 μl preincubated droplets
of KSOM medium before being placed into a droplet
containing sperm. Six hours later the oocytes were washed
three times in preincubated 20 μl droplets of KSOM medium
supplemented with 50 μg/ml gentamycin sulphate and BSA
(fraction V; Bayer, West Haven, CT, USA) and then cultured
for 4 days. Fertilization of the oocytes from the ovarian
grafts was performed at the same time as the collection
and fertilization of ovulated oocytes from the oviducts of
(superovulated) age-matched mice of the same strain.
These metaphase II (MII) oocytes served as controls were
therefore fertilized with the same sperm as the oocytes
that were collected from the ovarian grafts.
Experimental Design and Data Analysis. The
percentage of matured and fertilized oocytes were
calculated from the number of oocytes showed PB I
and 2 PN, respectively, per the number of GV oocytes x
100. The percentage of cleavage embryos were calculated
from the number of embryos at the  2 to 8 cells stages per
the number of GV oocytes cultured x 100. Data were
analized using general linear method by Duncan’s multiple
range test. Statistical significance was established at the
P < 0.05 level. The statistical analysis was performed on
the SPSS 17.0 program.
RESULTS
Ovarian grafts were successfully recovered from all
graft recipients in both without and with PMSG
stimulation, and showed of fully antral follicles
development (Figure 1a,b). As grafts at heterotopic site
do not allow spontaneous  conception, the oocytes have
to be harvested from the fully antral follicles for further in
vitro maturation (IVM) and fertilization (IVF). The average
number of oocytes collected from a pair of grafted ovaries
without and with PMSG stimulation were 9.0 + 2.8 and
10.9 + 5.1, respectively (P > 0.05). The average number of
oocytes from the grafted ovaries were significantly lower
compared with the superovulated nongrafted ovaries (as
control) (20.0 + 4.4) (Table 1). In contrast to the control
nongrafted ovaries, the number of oocytes recovered from
heterotopic autografted ovaries did not increase after
PMSG stimulation. And the overall average numbers of
oocytes from the grafted ovaries were significantly lower
compared with the superovulated nongrafted (control)
ovaries.
All oocytes collected from antral follicles of the grafts
recipients treated with PMSG were enclosed with tight
compact cumulus cells similar to the non PMSG stimulated
recipients  (Figure 2a). This tight enclosed-cumulus cells
indicated that the oocytes have not reached the matured
stage and examination after hyaluronidase treatment (nude
oocytes) under phase contrast microscope showed that
they were at the Germinal Vesicle (GV) stage (Figure 2b).
After in vitro maturation, the tight enclosed cumulus cells
showed extensive expansion (Figure 2c) and the matured
oocyte was determined by the presence of the first polar
body or the absence of the GV (Figure 2d). The percentage
of matured oocytes from the grafted ovaries without
PMSG stimulation was 52.4%, was not significantly
different with those that received PMSG stimulation
(53.2%); while the percentage of matured oocytes from
the control nongrafted ovaries was 84.4%, significantly
higher than those from the grafted ovaries (Table 2).
As the matured oocytes were inseminated, the sperm
will progressively move through the expanded cumulus
and penetrated into the zona pellucida and vitelline
membrane (Figure 2e). The penetration of sperm will
activate the oocyts to resumes the second meiosis and
extruded the second polar body (Figure 2f). The
percentage of fertilized oocytes (determined by the
presence of 2 pronuclei, Figure 2g) from grafted ovaries
without and with PMSG stimulation were 33.4 and 35.1%,
respectively (P > 0.05), signifantly lower than of the control
nongrafted ovaries (64.4%).
The percentage of cleavage embryos were 31.0 and
29.9% (P > 0.05) in grafted without and with PMSG
stimulation, respectively; but significantly lower compared
to those with the superovulated nongrafted ovaries 60.0%.
Table 1. Average number of oocytes collected from heterotopic autografted ovary with and without PMSG induction
Ovary treatment                                         No. of ovary                          Mean + SD per mouse                       Mean + SD per ovary
Autografted, no PMSG
Autografted, received PMSG
Nongrafted, received PMSG
10
10
10
9.0 + 2.8a
10.9 + 5.1a
20.0 + 4.4b
4.5 + 1.4a
5.5 + 2.6a
10.0 + 2.2b
Within coloumn a,b significantly different P < 0.05.
 
a b
k af
Figure 1. a. The transplanted halves ovary (arrow) under the
kidney (k) capsula; b. The grafted ovary after removed
from the kidney capsule, showed the developed antral
follicles (af).
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DISCUSSION
The number of oocytes recovered from the fully antral
follicles of heterotopic grafted ovaries with and without
PSMG induction was not significantly different; this
showed that PMSG induction does not significantly
increase the oocyte yield from ovarian grafts under the
kidney capsule. This result was in line with the previous
report in mice, that administration of exogenous
gonadotrophins does not significantly increase the oocyte
yield from ovarian grafts under the kidney capsule
(Waterhouse et al. 2004; Yang et al. 2006). And similar
result has also been reported that heterotopic mouse
ovarian xenografts failed to produce an increase in oocyte
yield in response to exogenous PMSG treatment (Snow et
al. 2002).
In contrast, the number of oocytes collected from
nongrafted ovaries were significantly higher compare to
the PSMG stimulated heterotopic grafted ovaries.
However, Waterhouse et al. (2004) reported that
superovulation treatment using PMSG on orthotopic
grafted ovaries also did not increase the oocytes yield.
This might be due to hormonal feedback between the
pituitary and ovary that regulates oocyte development
and may be disturbed by grafting and in particular grafting
to heterotopic sites. The kidney capsule graft site has a
relatively high vascularization that facilitates the
revascularization process which is essential for graft
establishment and the support of follicular growth (Cox et
al. 1996). However, the revascularization process depends
on several factors, such as the size of the tissue, the graft
site and the presence of angiogenic factors. In mouse,
with relatively small size ovaries, vascularization might
establish within 24-48 h of grafting (Dissen et al. 1994).
Prior to revascularization or post-transplant, the transplant
ovaries could undergo ischaemia that could cause for the
graft and follicles lost. As reported by Israely et al. (2006),
in mice, transplantation accounts for approximately 42%
of the loss in follicle population.
All oocytes collected from antral follicles of the grafted
ovaries (without and with PSMG induction) were enclosed
with tight compact cumulus cells (Figure 2a), indicate that
the oocytes have not reached the matured stage and
examination after hyaluronidase treatment (nude oocytes).
Under phase contrast microscope it was showed that they
were at the Germinal Vesicle (GV) stage (Figure 2b).
Gonadotropin stimulation in this research was performed
by administration of PMSG without hCG as the hormone
responsible for the GV breakdown.  However, Carroll et al.
(1990) and Waterhouse et al. (2004) collected oocytes from
Table 2. The percentage of oocytes in vitro maturation and fertilization and the embryo development
                                                                                                                                             Number of (%)
                                                                                            Matured (MII) oocytes           Fertilized oocytes          Cleavage embryo
Ovary treatment GV oocytes
Autografted, no PMSG
Autografted, received PMSG
Nongrafted, received PMSG
84
94
160
44 (52.4)a
50 (53.2)a
135 (84.4)b
28 (33.4)a
33 (35.1)a
103 (64.4)b
26 (31.0)a
28 (29.9)a
96 (60.0)b
Percentages are expressed as number of matured or fertilized oocytes or cleavage embryos per total GV oocytes. Within coloumn a,b
significantly different P < 0.05.
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Figure 2. Oocytes collected from antral follicles of the grafts recipients treated with PMSG a. Oocyte (o) with compact cumulus (cc)
isolated from the antral follicle; b. Oocyte at the GV stage; c. Oocytes with expanded cumulus (ec) cells after in vitro
maturation; d.  Oocyte at the metaphase II stage, the presence of the first polar body (pb1); e. Matured oocytes inseminated
with sperm (arrowhead); f. Extrusion of the second polar body after oocyte insemination; g. Fertilized oocyte with 2
pronuclei (arrow) and second polar body (pb2); h. Cleavage embryo at 4 cells stage. Bar: 50 μm (a,c,e); (b,f,g); (d,h).
ovarian grafts on the kidney 12 h after hCG injection
showed that the majority of the oocytes were at the GV
stage. This results may indicate that the follicular/oocyte
response to exogenous gonadotrophins at a heterotopic
site may not be normal. The reason for this is still
unknown, but it might be possible that the vascular
remodeling that occurs in the ovarian graft does not allow
adequate delivery of the gonadotrophin to the grafts.
This study examined the developmental potential of
oocytes collected from heterotopic  autografted ovaries
(at the kidney capsule). For producing embryo for
conception, oocytes collected from heterotopic grafts
required in vitro maturation (IVM) and in vitro fertilization
(IVF). Oocytes collected from ovarian grafts appear to
have a reduced developmental potential in comparison to
the oocytes produced from nongrafted ovaries. The
developmental competence (both the IVM and IVF) of
oocytes was lower in all the graft groups compared to the
superovulated oocytes from nongrafted ovaries. This
might be, in part, due to the oocytes from grafts
undergoing in vitro maturation or an effect of grafting
itself. The grafting process causes ischemic-reperfusion
injury that occurs as the graft establishes a new blood
supply. This period of poor vascular support may
adversely affect the oocyte and growing follicles. Damage
to the perivascular and endothelial cells was influence to
the  integrity of ovarian follicles and oocytes in ovarian
grafts (Israely et al. 2006). Ovarian grafting also disrupts
innervation of the ovary. The ovary is innervated by
extrinsic and intrinsic nerves that are believed to control
blood flow, as well as follicle and oocyte development
(Anesetti et al. 2001; D’Albora et al. 2002; Aguado 2002).
Normal follicle development and the production of viable
oocytes is a complicated process that involves
coordination of numerous molecules including hormones,
growth factors and receptors, in various signaling
pathways that act in autocrine, paracrine and endocrine
manners (Yamashita et al. 2000; Josefsberg & Dekel 2002;
Drummond et al. 2003). Although grafted ovaries do
become revascularized and reinnervated, the grafting
process may perturb the systems that are essential for
normal follicle growth and oocyte development and thus
result in a reduced number of developmentally competent
oocytes.
Oocytes from grafts in heterotopic groups are deprived
of local factors from the uterus or orthotopic site that are
required for normal follicle and oocyte development.
Furthermore, transplantation of ovarian tissue to other
sites within the body may disrupt some ovarian processes
and/or expose the ovary to a different environment.
Pregnant Mare Serum Gonadotropin (PMSG)
stimulation on heterotopic grafted ovaries did not increase
the number and quality of oocytes produced. The
development competence of oocytes produced from the
heterotopic autografted ovaries was lower than those from
stimulated nongrafted ovaries. Heterotopic autografted
ovaries produced oocytes that can be used for in vitro
embryo production after matured and fertilized in vitro.
REFERENCES
Almodin CG, Minquetti-Camara VC, Meister H, Ferreira JOHR,
Franco RL, Cavalcante AA.  2004a. Recovery of natural
fertility after grafting of cryopreserved germinative tissue in
ewes subjected to radiotherapy. Fertil Steril 81:160-164. http:/
/dx.doi.org/10.1016/j.fertnstert.2003.05.023
Almodin CG, Minquetti-Camara VC, Meister H, Ferreira JOHR,
Franco RL, Cavalcante AA. 2004b. Recovery of fertility after
grafting of cryopreserved germinative tissue in rabbit following
radiotherapy. Hum Reprod 19:1287-1293. http://dx.doi.org/
10.1093/humrep/deh246
Aguado LI. 2002. Role of central and perifer nervous system in
the ovarian function. Microsc Res Tech 59:462-473. http://
dx.doi.org/10.1002/jemt.10232
Anesetti G, Lombide O, D’Albora H, Ojeda SR. 2001. Instrinsic
neurons in the human ovary. Cell Tissue Res 306:231-237.
http://dx.doi.org/10.1007/s004410100451
Candy CJ, Wood MJ, Whittingham DG. 2000. Restoration of a
normal reproductive life spam after grafting of cryopreserved
ovaries. Hum Reprod 15:1300-1304. http://dx.doi.org/10.
1093/humrep/15.6.1300
Carroll J, Whittingham DG, Wood MJ, Tefler E, Gosden RG. 1990.
Extra-ovarian production of mature viable mouse oocytes
from frozen primary follicles. Reprod Fertil 90:321-327. http:/
/dx.doi.org/10.1530/jrf.0.0900321
Cox SL, Shaw J, Jenkin G. 1996. Transplantation of cryopreserved
fetal ovarian tissue to adult recipients in mice. Reprod Fertil
107:315-322. http://dx.doi.org/10.1530/jrf.0.1070315
D’Albora H, Anesetti G, Lombide P, Dees WL, Ojeda SR. 2002.
Intrinsic neurons in the rat ovary: an immunohistochemical
study. Cell Tissue Res 300:47-56. http://dx.doi.org/10.1007/
s004410050046
Dissen GA, Lara HE, Fahrenbach WH, Costa E, Ojeda SR. 1994.
Immature rat ovaries become revascularized rapidly after
autotransplantation and show a gonadotropin-dependent
increase in angiogenic factor gene expression. Endocrinology
134:1146-1154. http://dx.doi.org/10.1210/en.134.3.1146
Donnez J, Dolman MM, Demylle D, Jdoul P, Pirard C, Squifflet J.
2004. Livebirth after orthotopic transplantation of
cryopreserved ovarian tissue. Lancet 364:1405-1410. http://
dx.doi.org/10.1016/S0140-6736(04)17542-9
Drummond AE, Dyson M, Le MT, Ethier JF, Findlay JK. 2003.
Ovarian follicle population of the rat express TGF-beta
signalling pathways. Mol Cell Endoc 202:53-57. http://dx.
doi.org/10.1016/S0303-7207(03)00062-5
Eppig JJ, Sztein JM, O’Brien MJ, Farley s, Mobraaten LE. 2000.
Rescue of oocyte from antral follicles of cryopreserved mouse
ovaries: competence to undergo maturation, embryogenesis,
and development to term. Hum Reprod 15:167-571.
Fortune JE. 1994. Ovarian follicular growth and development in
mammals. Biol Reprod 50:225-232. http://dx.doi.org/10.1095/
biolreprod50.2.225
Gosden RG, Boulton MI, Grant K, Webb R. 1994. Follicular
development in cryopreserved marmoset ovarian in SCID mice.
Reprod Fertil 101:619-623. http://dx.doi.org/10.1530/jrf.0.
1010619
Gunasena KT, Lakey JRT, Villines PM, Bush M, Raath C, Critser
ES, McGann LE, Critser JK. 1998. Antral follicles develop in
xenografted cryopreserved African elephant (Loxodonta
africana) ovarian tissue. Anim Reprod Sci 53:265-275. http:/
/dx.doi.org/10.1016/S0378-4320(98)00132-8
Hernadi H, Mohamad K, Djuwita I. 2005. Allotransplantation of
newborn mice to adult mice: influence on the recipient estrous
cycle and donor ovary morphology. Jurnal Veteriner 6:143-
150.
Hirshfield AN. 1991. Development of follicles in the mammalian
ovary. Int Rev Cytol 124:43-101. http://dx.doi.org/10.1016/
S0074-7696(08)61524-7
Hogan B, Constantini F, Lacy E. 1986. Manipulating The Mouse
Embryo: A Laboratory Manual . Cold Spring Harbor
Laboratory.
Vol. 18, 2011                                          PMSG Induction of Ovary Heterotopic Transplantation     155
Israely T, Nava N, Alon H, Michael N, Alex T. 2006. Reducing
ischaemic damage in rodent ovarian xenografts transplanted
into granulation tissue. Hum Reprod 21:1368-1379. http://
dx.doi.org/10.1093/humrep/del010
Josefsberg LB, Dekel N. 2002. Translational and post-translational
modifications in meiosis of the mammalian oocyte. Mol Cell
Endoc 187:161-171. http://dx.doi.org/10.1016/S0303-7207
(01)00688-8
Liu J, Rybouchkin A, Van der Elst J, Dhont M. 2002. Fertilization
of mouse oocytes from in vitro-matured preantral follicles
using classical in vitro fertilization or intracytoplasmic sperm
injection. Biol Reprod 67:575-579. http://dx.doi.org/10.1095/
biolreprod67.2.575
Mohamad K, Budiarta K, Mudite IK, Djuwita I, Boediono A. 2003.
Oestrous cycle and uterine weight after subcutaneous ovary
autotransplantation in normal or superovulated mice. Hayati
10:100-105.
Mohammad K, Ramadhan IF, Djuwita I, Boediono A. 2004.
Comparison of oestrous cycle, uterine weight, and length of
pseudopregnancy of mice after ovary autografted in
subcutaneous and under the kidney capsule. Hayati 11:76-82.
Paris MCJ, Andersen CY, Shaw JM. 2009. Ovarian
cryopreservation and grafting: its potential for human
reproductive biology and animal conservation. Anim Reprod
6:96-113.
Paris MCJ, Snow M, Cox SL, Shaw JM. 2004.
Xenotransplantation: a tool for reproductive biology and
animal conservation? Theriogenology 61:277-291. http://dx.
doi.org/10.1016/S0093-691X(03)00234-6
Setiadi H. 2004. Follicles Development of Mice Renal
Subcapsullaris Transplant Ovary after PMSG Induction
[Thesis]. Bogor: Faculty of Veterinary Medicine, Bogor
Agricultural University.
Shaw JM, Oranratnachai A, Trounson AO. 2000. Fundamental
cryobiology of mammalian oocytes and ovarian tissue.
Theriogenology 53:59-72. http://dx.doi.org/10.1016/S0093-
691X(99)00240-X
Snow M, Cox SL, Jenkins G, Trounson A, Shaw J. 2002. Generation
of live young from xenografted mouse ovaries. Sciences
297:22-27. http://dx.doi.org/10.1126/science.1073693
Waterhouse T, Cox SL. Snow M, Jenkin G, Shaw J. 2004. Offspring
produced from heterotopic ovarian allografts in male and
female recipient mice. Reproduction 127:689-694. http://
dx.doi.org/10.1530/rep.1.00081
Yamashita M, Mita K, Yoshida N, Kondo T. 2000. Molecular
mechanisms of the initiation of oocytes maturation: general
and species-specific aspects. Progress in Cell Cycle Res 4:115-
129. http://dx.doi.org/10.1007/978-1-4615-4253-7_11
Yang HY, Cox SL, Jenkin G, Findlay J, Trounson A, Shaw J. 2006.
Graft site and gonadotropin stimulation influences the number
and quality of oocytes from murine ovarian tissue grafts.
Reproduction 131:851-859. http://dx.doi.org/10.1530/rep.1.
00916
156     NURBARIAH  ET AL.                                                                                                                                   HAYATI J Biosci
